Search alternatives:
nm decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nm decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1381
-
1382
-
1383
-
1384
-
1385
-
1386
Changes in outcome measures after treatment completion in the three groups.
Published 2022Subjects: -
1387
-
1388
Changes in vital signs (Week4 vs. Week0) after treatment completion within the three groups.
Published 2022Subjects: -
1389
-
1390
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement.
Published 2022Subjects: -
1391
-
1392
-
1393
-
1394
Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
Published 2024“…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
-
1395
Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
Published 2024“…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
-
1396
Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
Published 2024“…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
-
1397
-
1398
Changing Ce<sup>3+</sup> Content and Codoping Mn<sup>2+</sup> Induced Tunable Emission and Energy Transfer in Ca<sub>2.5</sub>Sr<sub>0.5</sub>Al<sub>2</sub>O<sub>6</sub>:Ce<sup>3+<...
Published 2016“…Ce<sup>3+</sup>, Mn<sup>2+</sup> codoped Ca<sub>2.5</sub>Sr<sub>0.5</sub>Al<sub>2</sub>O<sub>6</sub> phosphors also showed interesting luminescent properties when focused on the PL spectra excited at 365 nm. …”
-
1399
Changing Ce<sup>3+</sup> Content and Codoping Mn<sup>2+</sup> Induced Tunable Emission and Energy Transfer in Ca<sub>2.5</sub>Sr<sub>0.5</sub>Al<sub>2</sub>O<sub>6</sub>:Ce<sup>3+<...
Published 2016“…Ce<sup>3+</sup>, Mn<sup>2+</sup> codoped Ca<sub>2.5</sub>Sr<sub>0.5</sub>Al<sub>2</sub>O<sub>6</sub> phosphors also showed interesting luminescent properties when focused on the PL spectra excited at 365 nm. …”
-
1400